Alphabet lets AI take the lead role in new drug discovery startup
Last year, DeepMind produced a stunning advance in scientific research, using its AI to predict the 3D structures of unique proteins. This technology now forms the basis of a new spin-off from parent company Alphabet, called Isomorphic Labs. Source of Article